Cargando…

Synthesis of Clinical-Grade [(18)F]-Fluoroestradiol as a Surrogate PET Biomarker for the Evaluation of Estrogen Receptor-Targeting Therapeutic Drug

16α-[(18)F]-fluoroestradiol ([(18)F]FES), a steroid-based positron emission tomography (PET) tracer, has emerged as a dependable tracer for the evaluation and management of estrogen receptor-positive (ER+) breast cancer patients. We have developed a fully automatic, one-pot procedure for the synthes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dixit, Manish, Shi, Jianfeng, Wei, Ling, Afari, George, Bhattacharyya, Sibaprasad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665243/ https://www.ncbi.nlm.nih.gov/pubmed/23762549 http://dx.doi.org/10.1155/2013/278607

Ejemplares similares

Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiol
por: Jones, Ella F., et al.
Publicado: (2019)

Diagnostic and Prognostic Role of (18)F-Fluoroestradiol PET in Metastatic Breast Cancer: The Second Youth of an Older Theranostic Concept
por: Fiz, Francesco, et al.
Publicado: (2022)

Utility of [18F]-fluoroestradiol (FES) PET/CT with dedicated brain acquisition in differentiating brain metastases from posttreatment change in estrogen receptor-positive breast cancer
por: Ivanidze, Jana, et al.
Publicado: (2021)

The Preliminary Study of 16α-[18F]fluoroestradiol PET/CT in Assisting the Individualized Treatment Decisions of Breast Cancer Patients
por: Sun, Yifei, et al.
Publicado: (2015)

Quick Automatic Synthesis of Solvent-Free 16α-[(18)F] Fluoroestradiol: Comparison of Kryptofix 222 and Tetrabutylammonium Bicarbonate
por: Jiang, Xiao, et al.
Publicado: (2020)

Evaluation of tumour heterogeneity by (18)F-fluoroestradiol PET as a predictive measure in breast cancer patients receiving palbociclib combined with endocrine treatment
por: Liu, Cheng, et al.
Publicado: (2022)

18F-fluoroestradiol positron emission tomography in patients with breast cancer: a systematic review and meta-analysis
por: Matushita, Cristina S., et al.
Publicado: (2023)

Comparison of diagnostic sensitivity of [(18)F]fluoroestradiol and [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography for breast cancer recurrence in patients with a history of estrogen receptor-positive primary breast cancer
por: Chae, Sun Young, et al.
Publicado: (2020)

Safety and Effectiveness of F-18 Fluoroestradiol Positron Emission Tomography/Computed Tomography: a Systematic Review and Meta-analysis
por: Mo, Jin A
Publicado: (2021)

Can (18)F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with (18)F-Fluorodeoxyglucose Positron Emission Tomography?
por: Gupta, Manoj, et al.
Publicado: (2017)

Positron emission tomography of tumour [(18)F]fluoroestradiol uptake in patients with acquired hormone-resistant metastatic breast cancer prior to oestradiol therapy
por: van Kruchten, Michel, et al.
Publicado: (2015)

Evaluation of the early-phase [(18)F]AV45 PET as an optimal surrogate of [(18)F]FDG PET in ageing and Alzheimer’s clinical syndrome
por: Vanhoutte, Matthieu, et al.
Publicado: (2021)

Diagnostic Performance of [(18)F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer
por: Iqbal, Ramsha, et al.
Publicado: (2021)

Perfusion-Phase [(18)F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration
por: Brendel, Matthias, et al.
Publicado: (2017)

(18)F–Choline PET/CT Identifies High-Grade Prostate Cancer Lesions Expressing Bone Biomarkers
por: Urbano, Nicoletta, et al.
Publicado: (2019)

Early-phase [(18)F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury
por: Beyer, Leonie, et al.
Publicado: (2020)

An Intra-Individual Comparison of MRI, [(18)F]-FET and [(18)F]-FLT PET in Patients with High-Grade Gliomas
por: Nowosielski, Martha, et al.
Publicado: (2014)

Application of Positron Emission Tomography in Drug Development
por: Bhattacharyya, Sibaprasad
Publicado: (2012)

[(18)F]Fluciclovine PET discrimination between high- and low-grade gliomas
por: Parent, Ephraim E., et al.
Publicado: (2018)

[(18)F]-fluoro-l-thymidine PET and advanced MRI for preoperative grading of gliomas
por: Collet, S., et al.
Publicado: (2015)

Analyzing the Estrogen Receptor Status of Liver Metastases with [(18)F]-FES-PET in Patients with Breast Cancer
por: Boers, Jorianne, et al.
Publicado: (2021)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

(18)F-FET and (18)F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study
por: Mišir Krpan, Ana, et al.
Publicado: (2021)

Simplified and accessible [(18)F]F‐AraG synthesis procedure for preclinical PET
por: Högnäsbacka, Antonia A., et al.
Publicado: (2022)

Can Positron Emission Tomography/Computed Tomography with the Dual Tracers Fluorine-18 Fluoroestradiol and Fluorodeoxyglucose Predict Neoadjuvant Chemotherapy Response of Breast Cancer? ----A Pilot Study
por: Yang, Zhongyi, et al.
Publicado: (2013)

Limits of [(18)F]-FLT PET as a Biomarker of Proliferation in Oncology
por: McKinley, Eliot T., et al.
Publicado: (2013)

Evaluation of estrogen expression of breast cancer using (18)F-FES PET CT-A novel technique
por: Seenu, Vuthaluru, et al.
Publicado: (2020)

Prediction of prognosis and pathologic grade in follicular lymphoma using (18)F-FDG PET/CT
por: Li, Hongyan, et al.
Publicado: (2022)

Diagnostic and grading accuracy of (18)F-FDOPA PET and PET/CT in patients with gliomas: a systematic review and meta-analysis
por: Xiao, Jiarui, et al.
Publicado: (2019)

A Transmetalation Reaction Enables the Synthesis of [(18)F]5-Fluorouracil from [(18)F]Fluoride for Human PET Imaging
por: Hoover, Andrew J., et al.
Publicado: (2016)

Design and Synthesis of an (18)F-Labeled Version of Phenylethyl Orvinol ([(18)F]FE-PEO) for PET-Imaging of Opioid Receptors
por: Marton, János, et al.
Publicado: (2012)

Tracer‐specific reference tissues selection improves detection of (18)F‐FDG, (18)F‐florbetapir, and (18)F‐flortaucipir PET SUVR changes in Alzheimer's disease
por: Li, Yanxiao, et al.
Publicado: (2022)

Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using (18)F-FDG PET/CT
por: Park, Byungjoon, et al.
Publicado: (2015)

Case report: Low-grade myofibroblastic sarcoma resembling lymphoma on (18)F-FDG PET/CT
por: Zhang, Huan, et al.
Publicado: (2023)

Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats
por: Bolcaen, Julie, et al.
Publicado: (2016)

The association of (18)F-FDG PET/CT and biomarkers in confirming coronary microvascular dysfunction
por: Mayala, Henry Anselmo, et al.
Publicado: (2018)

The diagnostic performance of (18)F-FAMT PET and (18)F-FDG PET for malignancy detection: a meta-analysis
por: Achmad, Arifudin, et al.
Publicado: (2017)

Synthesis and Preclinical Characterization of [(18)F]FPBZA: A Novel PET Probe for Melanoma
por: Wu, Shih-Yen, et al.
Publicado: (2014)

Fully Automated Synthesis of Novel TSPO PET Imaging Ligand [(18)F]Fluoroethyltemazepam
por: Fiorenza, Dario, et al.
Publicado: (2021)

State of the art procedures towards reactive [(18)F]fluoride in PET tracer synthesis
por: Haveman, Lizeth Y. F., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_juag27g6qqp77at5f2h9a80oat